Cargando…

Pain in Fabry Disease: Could Spinal Cord Stimulation be a Solution?

Detalles Bibliográficos
Autores principales:	Buonanno, Pasquale, Capuano, Ivana, Riccio, Eleonora, Pisani, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2023
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10593308/ https://www.ncbi.nlm.nih.gov/pubmed/37881733 http://dx.doi.org/10.4103/ijn.IJN_100_21

Ejemplares similares

Stepwise shortening of agalsidase beta infusion duration in Fabry disease: Clinical experience with infusion rate escalation protocol
por: Riccio, Eleonora, et al.
Publicado: (2021)

Randomized Controlled Trials on Renin Angiotensin Aldosterone System Inhibitors in Chronic Kidney Disease Stages 3–5: Are They Robust? A Fragility Index Analysis
por: Capuano, Ivana, et al.
Publicado: (2022)

RAAS Inhibitor Prescription and Hyperkalemia Event in Patients With Chronic Kidney Disease: A Single-Center Retrospective Study
por: Riccio, Eleonora, et al.
Publicado: (2022)

Motor involvement in Fabry disease
por: Cocozza, Sirio, et al.
Publicado: (2017)

Switch from enzyme replacement therapy to oral chaperone migalastat for treating fabry disease: real-life data
por: Riccio, Eleonora, et al.
Publicado: (2020)

Spinal cord stimulation for a patient with neuropathic pain related to congenital syringomyelia
por: Beyaz, Serbülent Gökhan, et al.
Publicado: (2017)

Retrograde placement of spinal cord stimulator leads for treating resistant pelvic pain
por: Abd-Elsayed, Alaa, et al.
Publicado: (2017)

Agalsidase alfa and agalsidase beta in the treatment of Fabry disease: does the dose really matter?
por: Pisani, Antonio, et al.
Publicado: (2015)

Impact of COVID-19 pandemic on patients with Fabry disease: An Italian experience
por: Riccio, Eleonora, et al.
Publicado: (2020)

Thoracic spinal cord stimulation for low back pain in a patient with permanent pacemaker
por: Vassilakos, Dimitrios, et al.
Publicado: (2015)

Lead migration in spinal cord stimulation with loss of pain coverage in a CRPS patient
por: Hasoon, Jamal
Publicado: (2020)

Medication adherence in Fabry patients treated with migalastat: Real world experience
por: Riccio, Eleonora, et al.
Publicado: (2023)

Treatment of Chronic Back and Chest Pain in a Patient with Sickle Cell Disease Using Spinal Cord Stimulation
por: Yürük, Damla, et al.
Publicado: (2018)

The effects of somatostatin analogues on liver volume and quality of life in polycystic liver disease: a meta-analysis of randomized controlled trials
por: Garofalo, Carlo, et al.
Publicado: (2021)

DNA methylation impact on Fabry disease
por: Di Risi, Teodolinda, et al.
Publicado: (2021)

Fabry_CEP: a tool to identify Fabry mutations responsive to pharmacological chaperones
por: Cammisa, Marco, et al.
Publicado: (2013)

Late diagnosis of Fabry disease caused by a de novo mutation in a patient with end stage renal disease
por: Pisani, Antonio, et al.
Publicado: (2015)

Reduced Intracranial Volume in Fabry Disease: Evidence of Abnormal Neurodevelopment?
por: Pontillo, Giuseppe, et al.
Publicado: (2018)

Does left ventricular function predict cardiac outcome in Anderson–Fabry disease?
por: Spinelli, Letizia, et al.
Publicado: (2020)

What could be the expected solute clearance with single exchange of icodextrin?
por: Jeloka, T. K., et al.
Publicado: (2014)

Absence of infratentorial lesions in Fabry disease contributes to differential diagnosis with multiple sclerosis
por: Ugga, Lorenzo, et al.
Publicado: (2018)

Pathologic substrate of gastropathy in Anderson-Fabry disease
por: Di Toro, Alessandro, et al.
Publicado: (2020)

Comment: Why are females with Fabry disease affected?
por: Beck, Michael, et al.
Publicado: (2019)

A pilot study of circulating microRNAs as potential biomarkers of Fabry disease
por: Cammarata, Giuseppe, et al.
Publicado: (2018)

Escalation to high‐flow nasal cannula oxygen in hematological malignancy: the right choice at the right moment?
por: Buonanno, Pasquale, et al.
Publicado: (2022)

Effect of Paricalcitol vs Calcitriol on Hemoglobin Levels in Chronic Kidney Disease Patients: A Randomized Trial
por: Riccio, Eleonora, et al.
Publicado: (2015)

Fabry disease previously diagnosed as Henoch-Schonlein purpura
por: Kim, Ji Hyeong, et al.
Publicado: (2015)

ERT impact on left ventricular mass in Fabry disease
por: Ortiz, Alberto
Publicado: (2019)

Are Female Patients More Overlooked in the Diagnosis of Fabry Disease?
por: Gürdoğan, Muhammet, et al.
Publicado: (2020)

Optical Coherence Tomography Angiography Findings in Fabry Disease
por: Cennamo, Gilda, et al.
Publicado: (2019)

Delayed presentation of spinal cord trauma
por: Gupta, Babita, et al.
Publicado: (2011)

Spinal cord herniation: management and outcome
por: Groen, Rob J. M., et al.
Publicado: (2012)

Dermoid cyst splitting the spinal cord
por: Futane, Sameer S., et al.
Publicado: (2013)

The “Lip Sign” in MRI of the Spinal Cord
por: Tarafdar, Swarnava, et al.
Publicado: (2019)

Skin allergic reaction to a spinal cord stimulation (SCS): an analysis of the world literature and a case report
por: Woźniak-Dąbrowska, Kamila, et al.
Publicado: (2020)

Of the importance of the clinical phenotypes in the interpretation of the studies dealing with Fabry disease
por: Mauhin, Wladimir, et al.
Publicado: (2019)

Fabry Disease Associated With Antiglomerular Basement Membrane Disease: Chance or Consequence
por: Terinte-Balcan, George, et al.
Publicado: (2022)

High cervical spinal cord stimulation in Parkinson’s disease with dopamine-resistant axial disabilities: a case with 2-year follow-up
por: Lin, Zhengyu, et al.
Publicado: (2023)

The analgesic and antidepressant properties of dihydroartemisinine in the neuropathic pain mice: By the downregulation of HnRNPA1 in the spinal cord and hippocampus
por: Zhu, Chunyan, et al.
Publicado: (2022)

Oral Sucrosomial® iron versus intravenous iron for recovering iron deficiency anaemia in ND-CKD patients: a cost- minimization analysis
por: Riccio, Eleonora, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d00e8vlgdte6ro7d44ms4g6nr7